Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Griffith

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Nature Immunology|June 13, 2025
Physiological microbial exposure normalizes memory T cell surveillance of the brain and modifies host seizure outcomesMadison R Mix, Benjamin L Kreitlow, Roger R Berton, et al.
Shock (Augusta, Ga.)|October 30, 2025
Quantifying Nuance within Sepsis-Associated Immune Suppression toward Diagnostic CertaintyCharles C Caldwell, Robert Maile, Monty B Mazer, et al.
Scientific Reports|April 18, 2025
Determining potential immunomodulatory drug efficacy in sepsis using ELISpotAndrew H Walton, Monty B Mazer, Kenneth E Remy, et al.
Journal of Immunological Methods|August 15, 2024
Development and optimization of a diluted whole blood ELISpot assay to test immune functionRicardo F Ungaro, Julie Xu, Tamara A Kucaba, et al.
Science Advances|October 4, 2024
The generation of stable microvessels in ischemia is mediated by endothelial cell derived TRAILSiân P Cartland, Manisha S Patil, Elaina Kelland, et al.
Gut Microbes|October 16, 2023
Modulating microbiome-immune axis in the deployment-related chronic diseases of Veterans: report of an expert meetingJun Sun, M Nedim Ince, Clara Abraham, et al.
Frontiers in Immunology|October 29, 2024
Surviving septic patients endotyped with a functional assay demonstrate active immune responsesAdam D Price, Ellen R Becker, Evan L Barrios, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational StudyEvan A Barrios, Monty B Mazer, Patrick McGonagill, et al.
Nature Medicine|November 14, 2018
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockadeZiming Wang, Ethan G Aguilar, Jesus I Luna, et al.
JCI Insight|December 15, 2023
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpotEvan L Barrios, Monty B Mazer, Patrick W McGonagill, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Nature Immunology|June 13, 2025
Physiological microbial exposure normalizes memory T cell surveillance of the brain and modifies host seizure outcomesMadison R Mix, Benjamin L Kreitlow, Roger R Berton, et al.
Shock (Augusta, Ga.)|October 30, 2025
Quantifying Nuance within Sepsis-Associated Immune Suppression toward Diagnostic CertaintyCharles C Caldwell, Robert Maile, Monty B Mazer, et al.
Scientific Reports|April 18, 2025
Determining potential immunomodulatory drug efficacy in sepsis using ELISpotAndrew H Walton, Monty B Mazer, Kenneth E Remy, et al.
Journal of Immunological Methods|August 15, 2024
Development and optimization of a diluted whole blood ELISpot assay to test immune functionRicardo F Ungaro, Julie Xu, Tamara A Kucaba, et al.
Science Advances|October 4, 2024
The generation of stable microvessels in ischemia is mediated by endothelial cell derived TRAILSiân P Cartland, Manisha S Patil, Elaina Kelland, et al.
Gut Microbes|October 16, 2023
Modulating microbiome-immune axis in the deployment-related chronic diseases of Veterans: report of an expert meetingJun Sun, M Nedim Ince, Clara Abraham, et al.
Frontiers in Immunology|October 29, 2024
Surviving septic patients endotyped with a functional assay demonstrate active immune responsesAdam D Price, Ellen R Becker, Evan L Barrios, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational StudyEvan A Barrios, Monty B Mazer, Patrick McGonagill, et al.
Nature Medicine|November 14, 2018
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockadeZiming Wang, Ethan G Aguilar, Jesus I Luna, et al.
JCI Insight|December 15, 2023
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpotEvan L Barrios, Monty B Mazer, Patrick W McGonagill, et al.
Pageof 18